ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Discovery of novel DNA-damaging agents through phenotypic screening for DNA double-strand break.

https://repo.qst.go.jp/records/2000396
https://repo.qst.go.jp/records/2000396
c6b59e9c-6586-4379-9c03-74eabceb4b64
アイテムタイプ 学術雑誌論文 / Journal Article(1)
公開日 2024-01-26
タイトル
タイトル Discovery of novel DNA-damaging agents through phenotypic screening for DNA double-strand break.
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Doudou Zhang

× Doudou Zhang

Doudou Zhang

Search repository
Takashi Shimokawa

× Takashi Shimokawa

Takashi Shimokawa

Search repository
Qianqian Guo

× Qianqian Guo

Qianqian Guo

Search repository
Shingo Dan

× Shingo Dan

Shingo Dan

Search repository
Yoshio Miki

× Yoshio Miki

Yoshio Miki

Search repository
Shigeaki Sunada

× Shigeaki Sunada

Shigeaki Sunada

Search repository
抄録
内容記述タイプ Abstract
内容記述 DNA double-strand breaks (DSBs) seriously damage DNA and promote genomic instability that can lead to cell death. They are the source of conditions such as carcinogenesis and aging, but also have important applications in cancer therapy. Therefore, rapid detection and quantification of DSBs in cells are necessary for identifying carcinogenic and anticancer factors. In this study, we detected DSBs using a flow cytometry-based high-throughput method to analyze γH2AX intensity. We screened a chemical library containing 9600 compounds and detected multiple DNA-damaging compounds, although we could not identify mechanisms of action through this procedure. Thus, we also profiled a representative compound with the highest DSB potential, DNA-damaging agent-1 (DDA-1), using a bioinformatics-based method we termed "molecular profiling." Prediction and verification analysis revealed DDA-1 as a potential inhibitor of topoisomerase IIα, different from known inhibitors such as etoposide and doxorubicin. Additional investigation of DDA-1 analogs and xenograft models suggested that DDA-1 is a potential anticancer drug. In conclusion, our findings established that combining high-throughput DSB detection and molecular profiling to undertake phenotypic analysis is a viable method for efficient identification of novel DNA-damaging compounds for clinical applications.
書誌情報 Cancer science

巻 114, 号 3, p. 1108-1117, 発行日 2022-11
出版者
出版者 Wiley Publishing on behalf of the Japanese Cancer Association
ISSN
収録物識別子タイプ ISSN
収録物識別子 1349-7006
PubMed番号
識別子タイプ PMID
関連識別子 36385507
DOI
識別子タイプ DOI
関連識別子 10.1111/cas.15659
戻る
0
views
See details
Views

Versions

Ver.1 2025-08-15 02:18:25.259245
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3